Pharming Group N.V. Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities
Pharming Group N.V. (PHAR) reported Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities of -$10.44 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities · last filed 2026-04-02
EUR
| Period end | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2020-12-31 | 50.67M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Increase Decrease Through Financing Cash Flows Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2025-12-31 | -$10.44M 20-F · filed 2026-04-02 |
| 2024-12-31 | -$9.61M 20-F · filed 2025-04-03 |
| 2023-12-31 | -$9.17M 20-F · filed 2024-04-04 |
| 2022-12-31 | -$7.26M 20-F · filed 2023-04-05 |
| 2021-12-31 | -$32.66M 20-F · filed 2022-04-06 |